Fig. 3: Impact of COVID-19-related arrival restrictions on patient census.
From: Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach
Effective March 6, 2020, only higher urgency patients were accepted for evaluation and transplantation at the Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance (see also Table 2). Data are shown according to allogeneic and autologous transplant patients under our program’s care. As indicated, phase 1 of the ramp up was initiated on April 27, 2020.
